| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.59 | $1.43 | $1.24 | $1.67 | $2.20 | $1.45 | $1.92 | $1.40 |
| EPS (Diluted) | $1.57 | $1.42 | $1.23 | $1.66 | $2.18 | $1.44 | $1.90 | $1.38 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.8B | $15.2B | $14.6B | $12.1B | $9.7B | $8.3B | $7.1B | $6.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.5B | $0.4B | $0.2B | $0.7B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | $17.8B | $13.0B | $12.5B | $10.5B | $8.4B | $7.2B | $6.1B | $5.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.7B | $2.2B | $2.1B | $1.6B | $1.3B | $1.1B | $1.0B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.7B | $-0.6B | $0.5B | $-0.4B | $-0.4B | $-0.3B | $-0.3B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.4B | $0.5B | $-0.4B | $-0.4B | $0.6B | $0.6B | $0.2B | $0.1B |